Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

Rosseti North-West reported for 9 months of 2024 by RAS

10/31/24 MRKZ

Polyus received the first ton of gold from Sukhoi Log

10/31/24 PLZL

X5 reported for 9 months of 2024 by RAS

10/31/24 X5

Severstal reported for 9 months of 2024 by RAS

10/31/24 CHMF

Novoship reported for 9 months of 2024 by RAS

10/31/24 NOMP

Roman Avdeev sold a stake in Rossium to Sergey Sudarikov

10/31/24 CBOM

Board of Directors of IMCB recommended dividends

10/31/24 GEMA

Ozon Pharmaceuticals reported for 9 months of 2024 by RAS

10/31/24 OZPH

X5 Group opened its 700th OKOLO store

10/31/24 X5

Ozon launched a logistics complex in Yaroslavl

10/31/24 OZON